Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grant Miller

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Scientific Data|June 27, 2018
Time-lapse imagery and volunteer classifications from the Zooniverse Penguin Watch projectFiona M Jones, Campbell Allen, Carlos Arteta, et al.
Elife|May 19, 2022
A crowd of BashTheBug volunteers reproducibly and accurately measure the minimum inhibitory concentrations of 13 antitubercular drugs from photographs of 96-well broth microdilution platesPhilip W Fowler, Carla Wright, Helen Spiers, et al.
Alimentary Pharmacology & Therapeutics|February 14, 2025
Clinical Trial to Assess the Safety and Tolerability of Anti-IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol-Associated Liver DiseaseLuis Antonio Diaz, Sheldon Morris, Shravan Dave, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Scientific Data|June 27, 2018
Time-lapse imagery and volunteer classifications from the Zooniverse Penguin Watch projectFiona M Jones, Campbell Allen, Carlos Arteta, et al.
Elife|May 19, 2022
A crowd of BashTheBug volunteers reproducibly and accurately measure the minimum inhibitory concentrations of 13 antitubercular drugs from photographs of 96-well broth microdilution platesPhilip W Fowler, Carla Wright, Helen Spiers, et al.
Alimentary Pharmacology & Therapeutics|February 14, 2025
Clinical Trial to Assess the Safety and Tolerability of Anti-IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol-Associated Liver DiseaseLuis Antonio Diaz, Sheldon Morris, Shravan Dave, et al.
Pageof 6